Neurology

COVID-19 vaccination doesn’t seem to increase risk of relapse in multiple sclerosis

In this systematic review and meta-analysis, researchers analyzed 19 observational studies including 14,755 patients with MS who received 23,088 doses of COVID-19 vaccines. The mean age of patients was 43.3 years with 82.6% diagnosed with relapsing-remitting MS, 12.6% with secondary-progressive MS, 6.7% with primary-progressive MS, and 2.9% with clinically isolated...